Abstract:COPD is a chronic lung disorder characterized by a progressive and irreversible airflow obstruction, and persistent pulmonary inflammation. It has become a global epidemic affecting 10% of the population, and is the third leading cause of death worldwide. Respiratory viruses are a primary cause of COPD exacerbations, often leading to secondary bacterial infections in the lower respiratory tract. COPD patients are more susceptible to viral infections and associated severe disease, leading to accelerated lung function deterioration, hospitalization, and an increased risk of mortality. The airway epithelium plays an essential role in maintaining immune homeostasis, and orchestrates the innate and adaptive responses of the lung against inhaled and pathogen insults. A healthy airway epithelium acts as the first line of host defense by maintaining barrier integrity and the mucociliary escalator, secreting an array of inflammatory mediators, and initiating an antiviral state through the interferon (IFN) response. The airway epithelium is a major site of viral infection, and the interaction between respiratory viruses and airway epithelial cells activates host defense mechanisms, resulting in rapid virus clearance. As such, the production of IFNs and the activation of IFN signaling cascades directly contributes to host defense against viral infections and subsequent innate and adaptive immunity. However, the COPD airway epithelium exhibits an altered antiviral response, leading to enhanced susceptibility to severe disease and impaired IFN signaling. Despite decades of research, there is no effective antiviral therapy for COPD patients. Herein, we review current insights into understanding the mechanisms of viral evasion and host IFN antiviral defense signaling impairment in COPD airway epithelium. Understanding how antiviral mechanisms operate in COPD exacerbations will facilitate the discovery of potential therapeutic interventions to reduce COPD hospitalization and disease severity.

Advanced Research on Latent Adenoviral Infection in Chornic Obstructive Pulmonary Disease

[Latent Adenovirus Infection in Chronic Obstructive Pulmonary Disease].

Progress in diagnosis and treatment of adenoviral pneumonia complicated with bronchiolitis obliterans in children

Advance in Pathological Research and Pharmacological Therapies of Chronic Obstructive Pulmonary Disease

Research progress on viral infection and viral-bacterial co-infection in acute exacerbation of chronic obstructive pulmonary disease

Advances in research of inflammatory markers in chronic obstructive pulmonary disease

Research advance on interstitial lung disease associated cough

Respiratory viral infection: a potential “missing link” in the pathogenesis of COPD

The autoimmune mechanism in infectors of chronic obstructive pulmonary disease

Mechanisms of Virus-Induced Airway Immunity Dysfunction in the Pathogenesis of COPD Disease, Progression, and Exacerbation

Copd_a_196615 2725..2731

Exploration of Multi-Aspect Development of Chronic Obstructive Pulmonary Disease Pathogenesis, Diagnosis, and Treatment Management

Research Advances of Selective Anticholinergics in the Treatment of Chronic Obstructive Pulmonary Disease

The progress of the relationship between the pulmonary innate immunity and the exacerbation of COPD

Effects of Smoking on the Pathogenesis of Chronic Obstructive Pulmonary Disease

[Advances in Research on the Role of Alveolar Macrophage Burial Function in Chronic Obstructive Pulmonary Disease].

Chronic Obstructive Pulmonary Disease is Preventable and Curable

Immune Pathogenesy of Chronic Obstructive Pulmonary Disease with Respiratory Syncytial Virus Infection

[Annual review of progress in research on chronic obstructive pulmonary disease(2022-2023)]

Early Chronic Obstructive Pulmonary Disease: A New Perspective

Deciphering Respiratory-Virus-Associated Interferon Signaling in COPD Airway Epithelium